SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
IP Issues of Therapeutic Antibodies
1 references·1 citing·10 second hop
IP Issues of Therapeutic Antibodies (2012)IP Issues of Therapeutic AntibodiesThe Market For Follow-On Biologics: How Will It Evolve? (2006)The Market For Follow-On Biol…Patent disclosure requirements for therapeutic antibody patents (2017)Patent disclosure requirement…The price of innovation: new estimates of drug development costs (2003)Generic Competition in the US Pharmaceutical Industry (2006)The cost of biopharmaceutical R&D: is biotech different? (2007)The biotechnology sector and US gene patents: Legal challenges to intellectual property rights and the impact on basic research and development (2012)Determinants of Market Exclusivity for Prescription Drugs in the United States (2017)The Impact of the Entry of Biosimilars: Evidence from Europe (2018)European patent convention (1995)Patenting antibodies in Europe (2009)Patent litigation in Europe (2016)System Dynamics Modeling and Simulation of Enterprise Patent Management Optimization (2021)
this work references cited by second hop

References

  • 2006The Market For Follow-On Biologics: How Will It Evolve?79 cited

Cited by

  • 2017Patent disclosure requirements for therapeutic antibody patents4 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work